Afelimomab led to a modest mortality benefit in patients with severe sepsis and elevated interleukin-6 levels (Q21092899)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Afelimomab led to a modest mortality benefit in patients with severe sepsis and elevated interleukin-6 levels |
scientific article |
Statements
1 reference
Afelimomab led to a modest mortality benefit in patients with severe sepsis and elevated interleukin-6 levels (English)
1 reference
Eliseo Rondon
1 reference
Ramesh Venkataraman
1 reference